Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Baricitinib may effectively treat oral lichen planus.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Bortezomib chemotherapy can cause temporary skin rashes.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Drug repurposing shows promise for treating many medical conditions.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.